Riitta Lassila

435 total citations
12 papers, 351 citations indexed

About

Riitta Lassila is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Riitta Lassila has authored 12 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Pharmacology. Recurrent topics in Riitta Lassila's work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Inflammatory mediators and NSAID effects (2 papers) and Cell Adhesion Molecules Research (2 papers). Riitta Lassila is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Inflammatory mediators and NSAID effects (2 papers) and Cell Adhesion Molecules Research (2 papers). Riitta Lassila collaborates with scholars based in Finland and Netherlands. Riitta Lassila's co-authors include K. Laustiola, Marjo Tamminen, Hannele Yki‐Järvinen, Jukka Westerbacka, Janne T. Backman, Satu Vehkavaara, Julio C. Reséndiz, Leena E. Viiri, Pekka J. Karhunen and Jussi Mikkelsson and has published in prestigious journals such as International Journal of Obesity, Clinical Pharmacology & Therapeutics and Atherosclerosis.

In The Last Decade

Riitta Lassila

12 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Riitta Lassila Finland 9 210 92 81 79 72 12 351
MJ Silver United States 10 220 1.0× 115 1.3× 81 1.0× 57 0.7× 71 1.0× 21 496
Kavita Shalia India 10 127 0.6× 44 0.5× 74 0.9× 81 1.0× 8 0.1× 32 334
Tomohiro Sakamoto Japan 10 170 0.8× 14 0.2× 87 1.1× 56 0.7× 39 0.5× 11 370
Telly A. Meadows United States 5 318 1.5× 32 0.3× 156 1.9× 33 0.4× 75 1.0× 5 498
Ulrika Wall Sweden 13 154 0.7× 17 0.2× 76 0.9× 30 0.4× 72 1.0× 24 413
GG Nenci Italy 8 137 0.7× 40 0.4× 128 1.6× 14 0.2× 82 1.1× 18 328
Marcus E. McKenzie United States 8 144 0.7× 40 0.4× 52 0.6× 32 0.4× 65 0.9× 11 351
Michael S. Weinfeld United States 4 122 0.6× 21 0.2× 295 3.6× 95 1.2× 20 0.3× 5 444
Eiry Edmunds United Kingdom 8 173 0.8× 17 0.2× 45 0.6× 71 0.9× 15 0.2× 16 313

Countries citing papers authored by Riitta Lassila

Since Specialization
Citations

This map shows the geographic impact of Riitta Lassila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riitta Lassila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riitta Lassila more than expected).

Fields of papers citing papers by Riitta Lassila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riitta Lassila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riitta Lassila. The network helps show where Riitta Lassila may publish in the future.

Co-authorship network of co-authors of Riitta Lassila

This figure shows the co-authorship network connecting the top 25 collaborators of Riitta Lassila. A scholar is included among the top collaborators of Riitta Lassila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riitta Lassila. Riitta Lassila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Bot, Ilze, Peter J. van Santbrink, Amanda C. Foks, et al.. (2024). Treatment with APAC, a dual antiplatelet anticoagulant heparin proteoglycan mimetic, limits early collar-induced carotid atherosclerotic plaque development in Apoe−/− mice. Atherosclerosis. 397. 118567–118567. 2 indexed citations
2.
Tuuminen, Raimo, Annukka Jouppila, S. Syrjälä, et al.. (2016). Dual antiplatelet and anticoagulant APAC prevents experimental ischemia–reperfusion-induced acute kidney injury. Clinical and Experimental Nephrology. 21(3). 436–445. 20 indexed citations
3.
Tornio, Aleksi, Lotta Joutsi‐Korhonen, Mikko Neuvonen, et al.. (2012). Grapefruit juice markedly increases the plasma concentrations and antiplatelet effects of ticagrelor in healthy subjects. British Journal of Clinical Pharmacology. 75(6). 1488–1496. 28 indexed citations
4.
Salmela, Birgitta, et al.. (2010). Comparison of monitoring methods for lepirudin: Impact of warfarin and lupus anticoagulant. Thrombosis Research. 125(6). 538–544. 11 indexed citations
5.
Virtanen, Kari, Julio C. Reséndiz, Jussi Mikkelsson, et al.. (2009). Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions – Limited inhibition of the P2Y12 receptor. Thrombosis Research. 124(2). 193–198. 7 indexed citations
6.
Käpylä, Jarmo, Beate Eckes, Mark S. Johnson, et al.. (2009). A small-molecule inhibitor of integrin α2β1 introduces a new strategy for antithrombotic therapy. Thrombosis and Haemostasis. 103(2). 387–397. 31 indexed citations
7.
Mikkelsson, Jussi, Julio C. Reséndiz, Leena E. Viiri, et al.. (2006). Polymorphisms of COX-1 and GP VI associate with the antiplatelet effect of aspirin in coronary artery disease patients. Thrombosis and Haemostasis. 95(2). 253–259. 83 indexed citations
8.
Ylikorkala, Olavi, Bruno Cacciatore, Riitta Lassila, et al.. (2003). Effects of ospemifene, a novel SERM, on vascular markers and function in healthy, postmenopausal women. Menopause The Journal of The North American Menopause Society. 10(5). 440–447. 37 indexed citations
9.
Tamminen, Marjo, Riitta Lassila, Jukka Westerbacka, Satu Vehkavaara, & Hannele Yki‐Järvinen. (2003). Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects. International Journal of Obesity. 27(8). 907–911. 70 indexed citations
10.
Sarlomo‐Rikala, Maarit, et al.. (2000). Immunohistochemical evaluation of failed vessel anastomoses in clinical microsurgery. British Journal of Plastic Surgery. 53(7). 567–573. 12 indexed citations
11.
12.
Laustiola, K., et al.. (1988). Enhanced activation of the renin-angiotensin-aldosterone system in chronic cigarette smokers: A study of monozygotic twin pairs discordant for smoking. Clinical Pharmacology & Therapeutics. 44(4). 426–430. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by MJ Silver Breakdown of academic impact, for papers by Kavita Shalia Breakdown of academic impact, for papers by Tomohiro Sakamoto Breakdown of academic impact, for papers by Telly A. Meadows Breakdown of academic impact, for papers by Ulrika Wall Breakdown of academic impact, for papers by GG Nenci Breakdown of academic impact, for papers by Marcus E. McKenzie Breakdown of academic impact, for papers by Michael S. Weinfeld Breakdown of academic impact, for papers by Eiry Edmunds
Rankless by CCL
2026